DK0623172T3 - Rekombinant Mareks sygdomsvirus-poxvirusvaccine - Google Patents

Rekombinant Mareks sygdomsvirus-poxvirusvaccine

Info

Publication number
DK0623172T3
DK0623172T3 DK93902962T DK93902962T DK0623172T3 DK 0623172 T3 DK0623172 T3 DK 0623172T3 DK 93902962 T DK93902962 T DK 93902962T DK 93902962 T DK93902962 T DK 93902962T DK 0623172 T3 DK0623172 T3 DK 0623172T3
Authority
DK
Denmark
Prior art keywords
disease virus
vaccine
recombinant marek
poxvirus vaccine
virus poxvirus
Prior art date
Application number
DK93902962T
Other languages
Danish (da)
English (en)
Inventor
Louis Ross
Enzo Paoletti
James Tartaglia
Jill Taylor
Original Assignee
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogenetics Corp filed Critical Virogenetics Corp
Application granted granted Critical
Publication of DK0623172T3 publication Critical patent/DK0623172T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK93902962T 1992-01-13 1993-01-07 Rekombinant Mareks sygdomsvirus-poxvirusvaccine DK0623172T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82007792A 1992-01-13 1992-01-13
US139193A 1993-01-06 1993-01-06
EP93902962A EP0623172B1 (de) 1992-01-13 1993-01-07 Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus
PCT/US1993/000084 WO1993014219A1 (en) 1992-01-13 1993-01-07 Marek's disease virus recombinant poxvirus vaccine

Publications (1)

Publication Number Publication Date
DK0623172T3 true DK0623172T3 (da) 2005-04-25

Family

ID=26668976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93902962T DK0623172T3 (da) 1992-01-13 1993-01-07 Rekombinant Mareks sygdomsvirus-poxvirusvaccine

Country Status (10)

Country Link
EP (2) EP1489165A1 (de)
JP (1) JP3706130B2 (de)
AT (1) ATE286137T1 (de)
AU (1) AU680609B2 (de)
CA (1) CA2127700C (de)
DE (1) DE69333728T2 (de)
DK (1) DK0623172T3 (de)
ES (1) ES2236684T3 (de)
PT (1) PT623172E (de)
WO (1) WO1993014219A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
AU696247B2 (en) * 1993-02-26 1998-09-03 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
EP0905140B9 (de) * 1996-03-29 2009-05-13 Zeon Corporation Neues fusionsprotein, dafuer kodierendes gen, rekombinanter vektor, rekombinantes virus und dessen verwendung
GB2460694A (en) * 2008-06-06 2009-12-09 Secr Defence Attenuated poxviruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
EP0284416B1 (de) * 1987-03-27 1995-02-22 Nippon Zeon Co., Ltd. Rekombinantes Avipoxvirus
DE10399031I1 (de) * 1987-08-28 2004-01-29 Health Research Inc Rekombinante Viren.
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
GB2220941B (en) * 1988-06-24 1991-09-11 Nat Res Dev Fowlpox virus non-essential regions
JP3339854B2 (ja) * 1988-09-13 2002-10-28 メリアル ウイルスワクチン
WO1992022641A1 (en) * 1991-06-14 1992-12-23 Virogenetics Corporation Immunodeficiency virus recombinant poxvirus vaccine
BE1004877A3 (fr) * 1991-05-27 1993-02-16 Solvay Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.
US5369025A (en) * 1991-06-28 1994-11-29 The United States Of America As Represented By The Secretary Of Agriculture Recombinant fowlpox vaccine for protection against Marek's disease

Also Published As

Publication number Publication date
EP0623172B1 (de) 2004-12-29
AU680609B2 (en) 1997-08-07
DE69333728T2 (de) 2006-08-31
ES2236684T3 (es) 2005-07-16
JPH07503843A (ja) 1995-04-27
CA2127700C (en) 2006-06-20
EP0623172A1 (de) 1994-11-09
CA2127700A1 (en) 1993-07-22
JP3706130B2 (ja) 2005-10-12
PT623172E (pt) 2005-02-28
AU3435393A (en) 1993-08-03
ATE286137T1 (de) 2005-01-15
DE69333728D1 (de) 2005-02-03
EP0623172A4 (de) 1995-08-09
WO1993014219A1 (en) 1993-07-22
EP1489165A1 (de) 2004-12-22

Similar Documents

Publication Publication Date Title
IT9019623A0 (it) Sistema di selezione di spettro di infettivita' di poxvirus ricombinante
IT1241119B (it) Vaccino di poxvirus ricombinante di herpesvirus
GB2269820A (en) Flavivirus recombinant poxvirus vaccine
DE69529219T2 (de) Helicobacter proteine und impstoffe
DE68927025D1 (de) HIV-2-Virusvarianten
DE3853088D1 (de) Rekombinantes Avipoxvirus.
DE3888086D1 (de) Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine.
DK0592546T3 (da) Immundeficiens-virus rekombinant poxvirus-vaccine
DE3677494D1 (de) Virus-impfstoff.
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
ES2078255T3 (es) Regiones inmunogenas en la proteina e-7 del papilomavirus humano tipo 16.
ATE120489T1 (de) Rekombinante coccidiosis-vakzine.
FR2620459B1 (fr) Virus recombinant de la vaccine
ATE117369T1 (de) Rekombinantes virus der marekschen krankheit und vakzin.
ZA923321B (en) Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus
DE69101683D1 (de) Rekombinantes Mareks-Krankheitsvirus.
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
GB2264949A (en) Measles virus recombinant poxvirus vaccine
LU91303I2 (fr) Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP
DK0623172T3 (da) Rekombinant Mareks sygdomsvirus-poxvirusvaccine
EP0496787A4 (en) Novel infectious bursal disease virus
DE59209310D1 (de) Impfstoffe auf Basis geänderter Boviner Herpesviren Typ 1
IT1228928B (it) Procedimento per l'ottenimento di un vaccino ricombinante contro l'epatite b.
DK0547873T3 (da) En hidtil ukendt translationsaktiverende sekvens
ATE102252T1 (de) Rekombinantes gefluegelpockenvirus, expressionsvektoren fuer heterologische proteine und davon derivierte gefluegelvakzine.